622
Views
30
CrossRef citations to date
0
Altmetric
Cardiology and Vascular Disease: Original Articles

Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials

, , , , , , , , & show all
Pages 369-378 | Accepted 30 Jan 2013, Published online: 18 Feb 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Chao Ma, Tao Gao, Jun Ju, Yi Zhang, Qianwei Ni, Yun Li, Zhenyan Zhao, Juan Chai, Xiangming Yang & Moyi Sun. (2019) Sympathetic innervation contributes to perineural invasion of salivary adenoid cystic carcinoma via the β2-adrenergic receptor. OncoTargets and Therapy 12, pages 1475-1495.
Read now

Articles from other publishers (29)

Hyun Chang & Sung Hyun Lee. (2022) Beta-adrenergic receptor blockers and hepatocellular carcinoma survival: a systemic review and meta-analysis. Clinical and Experimental Medicine 23:3, pages 853-858.
Crossref
James Yarmolinsky, Virginia Díez-Obrero, Tom G. Richardson, Marie Pigeyre, Jennifer Sjaarda, Guillaume Paré, Venexia M. Walker, Emma E. Vincent, Vanessa Y. Tan, Mireia Obón-Santacana, Demetrius Albanes, Jochen Hampe, Andrea Gsur, Heather Hampel, Rish K. Pai, Mark Jenkins, Steven Gallinger, Graham Casey, Wei Zheng, Christopher I. Amos, George Davey Smith, Richard M. Martin & Victor Moreno. (2022) Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis. PLOS Medicine 19:2, pages e1003897.
Crossref
Marco Cosentino & Franca Marino. 2022. Endocrine Pathology. Endocrine Pathology 119 120 .
Marco Cosentino & Franca Marino. 2020. Encyclopedia of Pathology. Encyclopedia of Pathology 1 2 .
Rong Yang, Yonggang Zhang, Xiaoyang Liao, Yi Yao, Chuanying Huang & Lixia Liu. (2020) The Relationship Between Anti-Hypertensive Drugs and Cancer: Anxiety to be Resolved in Urgent. Frontiers in Pharmacology 11.
Crossref
Eva Y. F. Chan, Danny K. Y. Ip & Michael G. Irwin. 2020. Esophageal Squamous Cell Carcinoma. Esophageal Squamous Cell Carcinoma 359 383 .
Wen-Shuo Yeh, Shih-Cheng Yang, Chih-Ming Liang, Yu-Chi Li, Wei-Chen Tai, Chen-Hsiang Lee, Yao-Hsu Yang, Chien-Ning Hsu, Tzu-Hsien Tsai, Seng-Kee Chuah & Cheng-Kun Wu. (2019) The Role of Non-Selective β-Blockers in Compensated Cirrhotic Patients without Major Complications. Medicina 56:1, pages 14.
Crossref
Altaf Mohammed, Jennifer T Fox & Mark Steven Miller. (2019) Cancer Chemoprevention: Preclinical In Vivo Alternate Dosing Strategies to Reduce Drug Toxicities. Toxicological Sciences 170:2, pages 251-259.
Crossref
Ping-Ying Chang, Chi-Hsiang Chung, Wei-Chou Chang, Chun-Shu Lin, Hsuan-Hwai Lin, Ming-Shen Dai, Ching-Liang Ho & Wu-Chien Chien. (2019) The effect of propranolol on the prognosis of hepatocellular carcinoma: A nationwide population-based study. PLOS ONE 14:5, pages e0216828.
Crossref
Guanxi Qiao, Minhui Chen, Mark J. Bucsek, Elizabeth A. Repasky & Bonnie L. Hylander. (2018) Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response. Frontiers in Immunology 9.
Crossref
Bingbing Wang, Nataliya Parobchak, Adriana Martin, Max Rosen, Lumeng Jenny Yu, Mary Nguyen, Kseniya Gololobova & Todd Rosen. (2018) Screening a small molecule library to identify inhibitors of NF-κB inducing kinase and pro-labor genes in human placenta. Scientific Reports 8:1.
Crossref
Monique B. Nilsson, Huiying Sun, Lixia Diao, Pan TongDiane Liu, Lerong LiYouhong FanAlissa Poteete, Seung-Oe Lim, Kathryn HowellsVincent Haddad, Daniel GomezHai TranGuillermo Armaiz PenaLecia V. Sequist, James C. Yang, Jing WangEdward S. Kim, Roy S. HerbstJ. Jack Lee, Waun Ki HongIgnacio Wistuba, Mien-Chie Hung, Anil K. SoodJohn V. Heymach. (2017) Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with β-blockers. Science Translational Medicine 9:415.
Crossref
Lucía Gargiulo, María May, Ezequiel M. Rivero, Sabrina Copsel, Caroline Lamb, John Lydon, Carlos Davio, Claudia Lanari, Isabel A. Lüthy & Ariana Bruzzone. (2017) A Novel Effect of β-Adrenergic Receptor on Mammary Branching Morphogenesis and its Possible Implications in Breast Cancer. Journal of Mammary Gland Biology and Neoplasia 22:1, pages 43-57.
Crossref
Marisa Coelho, Cátia Soares-Silva, Daniela Brandão, Franca Marino, Marco Cosentino & Laura Ribeiro. (2016) β-Adrenergic modulation of cancer cell proliferation: available evidence and clinical perspectives. Journal of Cancer Research and Clinical Oncology 143:2, pages 275-291.
Crossref
Kalle J Kaapu, Teemu J Murtola, Kirsi Talala, Kimmo Taari, Teuvo LJ Tammela & Anssi Auvinen. (2016) Digoxin and prostate cancer survival in the Finnish Randomized Study of Screening for Prostate Cancer. British Journal of Cancer 115:11, pages 1289-1295.
Crossref
Hye-Young Min, Hye-Jin Boo, Ho Jin Lee, Hyun-Ji Jang, Hye Jeong Yun, Su Jung Hwang, John Kendal Smith, Hyo-Jong Lee & Ho-Young Lee. (2016) Smoking-associated lung cancer prevention by blockade of the beta-adrenergic receptor-mediated insulin-like growth factor receptor activation. Oncotarget 7:43, pages 70936-70947.
Crossref
Kazuyoshi Hirota. (2016) Adrenoceptor modulators and cancer progression. Journal of Anesthesia 30:3, pages 365-368.
Crossref
Hamid Zand, Reza Homayounfar, Makan Cheraghpour, Mahmood Jeddi-Tehrani, Arman Ghorbani, Katayoun Pourvali & Sama Reza Soltani. (2016) Obesity-induced p53 activation in insulin-dependent and independent tissues is inhibited by beta-adrenergic agonist in diet-induced obese rats. Life Sciences 147, pages 103-109.
Crossref
K. J. Kaapu, T. J. Murtola, L. Määttänen, K. Talala, K. Taari, T. L. J. Tammela & A. Auvinen. (2015) Prostate cancer risk among users of digoxin and other antiarrhythmic drugs in the Finnish Prostate Cancer Screening Trial. Cancer Causes & Control 27:2, pages 157-164.
Crossref
Giovanna Talarico, Stefania Orecchioni, Katiuscia Dallaglio, Francesca Reggiani, Patrizia Mancuso, Angelica Calleri, Giuliana Gregato, Valentina Labanca, Teresa Rossi, Douglas M. Noonan, Adriana Albini & Francesco Bertolini. (2016) Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells. Scientific Reports 6:1.
Crossref
W. Kurtis Childers, Christopher S. Hollenbeak & Pramil Cheriyath. (2015) β-Blockers Reduce Breast Cancer Recurrence and Breast Cancer Death: A Meta-Analysis. Clinical Breast Cancer 15:6, pages 426-431.
Crossref
Ping-Ying Chang, Wen-Yen Huang, Cheng-Li Lin, Tzu-Chuan Huang, Yi-Ying Wu, Jia-Hong Chen & Chia-Hung Kao. (2015) Propranolol Reduces Cancer Risk. Medicine 94:27, pages e1097.
Crossref
Luca Filippi, Massimo Dal Monte, Giovanni Casini, Marta Daniotti, Federica Sereni & Paola Bagnoli. (2015) Infantile Hemangiomas, Retinopathy of Prematurity and Cancer: A Common Pathogenetic Role of the β-Adrenergic System. Medicinal Research Reviews 35:3, pages 619-652.
Crossref
Rocío Porcel Chacón, Javier del Boz González & Juan Navarro Morón. (2015) Delayed-Onset of Multiple Cutaneous Infantile Hemangiomas Due to Propranolol: A Case Report. Pediatrics 135:4, pages e1064-e1066.
Crossref
Shahid Akbar & Mansour Saleh Alsharidah. (2014) Are Beta Blockers New Potential Anticancer Agents?. Asian Pacific Journal of Cancer Prevention 15:22, pages 9567-9574.
Crossref
Salvatore Patan?. (2014) HERG-targeted therapy in both cancer and cardiovascular system with cardiovascular drugs. International Journal of Cardiology 176:3, pages 1082-1085.
Crossref
Mark F. McCarty. (2014) A role for cAMP-driven transactivation of EGFR in cancer aggressiveness – Therapeutic implications. Medical Hypotheses 83:2, pages 142-147.
Crossref
Salvatore Patan?. (2014) Heart Failure and Breast Cancer: Emerging Controversies Regarding Some Cardioprotective Strategies. Journal of Cardiac Failure 20:6, pages 456-457.
Crossref
Edoardo Botteri, Elisabetta Munzone, Nicole Rotmensz, Carlo Cipolla, Vincenzo De Giorgi, Barbara Santillo, Arnaldo Zanelotti, Laura Adamoli, Marco Colleoni, Giuseppe Viale, Aron Goldhirsch & Sara Gandini. (2013) Therapeutic effect of ?-blockers in triple-negative breast cancer postmenopausal women. Breast Cancer Research and Treatment 140:3, pages 567-575.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.